AAAAAA

   
Results: 1-8 |
Results: 8
CLINICAL IMPACT OF PHARMACOKINETICALLY-GUIDED DOSE ADAPTATION OF 5-FLUOROURACIL - RESULTS FROM A MULTICENTRIC RANDOMIZED TRIAL IN PATIENTS WITH LOCALLY ADVANCED HEAD AND NECK CARCINOMAS
Authors: FETY R ROLLAND F BARBERIHEYOB M HARDOUIN A CAMPION L CONROY T MERLIN JL RIVIERE A PERROCHEAU G ETIENNE MC MILANO G
Citation: R. Fety et al., CLINICAL IMPACT OF PHARMACOKINETICALLY-GUIDED DOSE ADAPTATION OF 5-FLUOROURACIL - RESULTS FROM A MULTICENTRIC RANDOMIZED TRIAL IN PATIENTS WITH LOCALLY ADVANCED HEAD AND NECK CARCINOMAS, Clinical cancer research, 4(9), 1998, pp. 2039-2045
NEW MECHANISM OF BRCA-1 MUTATION BY DELETION INSERTION AT THE SAME NUCLEOTIDE POSITION IN 3 UNRELATED FRENCH BREAST/OVARIAN CANCER FAMILIES/
Authors: PRESNEAU N LAPLACEMARIEZE V SYLVAIN V LORTHOLARY A HARDOUIN A BERNARDGALLON D BIGNON YJ
Citation: N. Presneau et al., NEW MECHANISM OF BRCA-1 MUTATION BY DELETION INSERTION AT THE SAME NUCLEOTIDE POSITION IN 3 UNRELATED FRENCH BREAST/OVARIAN CANCER FAMILIES/, Human genetics, 103(3), 1998, pp. 334-339
HIGH-DOSE 5FU BIOMODULATION BY HIGH-DOSE LEUCOVORIN AND INDIVIDUAL 5FU DOSE ADJUSTMENT IN METASTATIC COLORECTAL-CANCER - A MULTICENTRIC PROSPECTIVE-STUDY OF 130 PATIENTS
Authors: GAMELIN E DELVA R DUMASNIL Y JACOB J MAILLART P CALLE MB GOUDIER MJ LORTHOLARY A HARDOUIN A GESLIN J HETROY J LARRA F
Citation: E. Gamelin et al., HIGH-DOSE 5FU BIOMODULATION BY HIGH-DOSE LEUCOVORIN AND INDIVIDUAL 5FU DOSE ADJUSTMENT IN METASTATIC COLORECTAL-CANCER - A MULTICENTRIC PROSPECTIVE-STUDY OF 130 PATIENTS, European journal of cancer, 31A, 1995, pp. 729-729
AN EVALUATION OF GENETIC-HETEROGENEITY IN 145 BREAST-CANCER OVARIAN-CANCER FAMILIES
Authors: NAROD SA FORD D DEVILEE P BARKARDOTTIR RB LYNCH HT SMITH SA PONDER BAJ WEBER BL GARBER JE BIRCH JM CORNELIS RS KELSELL DP SPURR NK SMYTH E HAITES N SOBOL H BIGNON YJ CHANGCLAUDE J HAMANN U LINDBLOM A BORG A PIVER MS GALLION HH STRUEWING JP WHITTEMORE A TONIN P GOLDGAR DE EASTON DF MILNER B ALLAN L SIMARD J ROMMENS J MCGILLIVRAY B GREEN R IVES E BOYD N ROSEN B COLE D MORGAN K MOSLEHI R PONDER B PETO J SMITH S STRATTON M DICIOCCIO RA GALLION H SANTIBANEZKOREF MS TEARE MD EVANS DG STOPPALYONNET D LALLE P BONAITI C ESSIOUX L GIRODET C MAUGARDLOUBOUTIN C NICOLLEAU G LONGY M TOULOUSE C HORSTEIN I BIRNBAUM D EISINGER F KARENGUEVEN F NOGUCHI T HARDOUIN A RIO P MACHELARDROUMAGNAC M NOGUES C COHENHAGUENAUER O LORTHOLARY A BAY JO ARASON A BARKDARDOTTIR RB EGILSSON V BISHOP DT KELSELL D MURDAY VA SOLOMON E SPURR N TURNER G LENOIR G FEUNTEUN J LYNCH H LYNCH J WATSON P CONWAY T BONNARDEL C SEROVA O TORCHARD D LARSSON C VASEN H VANLEEUWEN I CORNELISSE CJ STEEL M PORTER D COHEN BB CAROTHERS A CANNONALBRIGHT LA GOLDGAR D SKOLNICK M BECHER H JOHANNSSON O WEBER B COLLINS F BOEHNKE M GARBER J LI F
Citation: Sa. Narod et al., AN EVALUATION OF GENETIC-HETEROGENEITY IN 145 BREAST-CANCER OVARIAN-CANCER FAMILIES, American journal of human genetics, 56(1), 1995, pp. 254-264
CLINICAL RANDOMIZED STUDY OF 5FU MONITORING VERSUS STANDARD-DOSE IN PATIENTS WITH HEAD AND NECK-CANCER - PRELIMINARY-RESULTS
Authors: FETY R ROLLAND F BARBERIHEYOB M MERLIN JL CONROY T HARDOUIN A RIVIERE A MILANO G
Citation: R. Fety et al., CLINICAL RANDOMIZED STUDY OF 5FU MONITORING VERSUS STANDARD-DOSE IN PATIENTS WITH HEAD AND NECK-CANCER - PRELIMINARY-RESULTS, Anticancer research, 14(6A), 1994, pp. 2347-2352
FAMILIAL SITE-SPECIFIC OVARIAN-CANCER IS LINKED TO BRCA1 ON 17Q12-21
Authors: STEICHENGERSDORF E GALLION HH FORD D GIRODET C EASTON DF DICIOCCIO RA EVANS G PONDER MA PYE C MAZOYER S NOGUCHI T KARENGUEVEN F SOBOL H HARDOUIN A BIGNON YJ PIVER MS SMITH SA PONDER BAJ
Citation: E. Steichengersdorf et al., FAMILIAL SITE-SPECIFIC OVARIAN-CANCER IS LINKED TO BRCA1 ON 17Q12-21, American journal of human genetics, 55(5), 1994, pp. 870-875
MOLECULAR-GENETIC STUDY OF 28 FRENCH FAMI LIES WITH HISTORY OF GYNECOLOGICAL CANCER
Authors: RIO P GIRODET C LALLE P LYONNET D HARDOUIN A SOBOL H BIGNON YJ
Citation: P. Rio et al., MOLECULAR-GENETIC STUDY OF 28 FRENCH FAMI LIES WITH HISTORY OF GYNECOLOGICAL CANCER, La Revue de medecine interne, 14(6), 1993, pp. 456-456
GENETIC PREDISPOSITION TO BREAST-CANCER A ND OVARIAN-CANCER
Authors: LALLE P STOPPALYONNET D MAZOYER S RIO P GIRODET C HARDOUIN A NAROD SA SOBOL H BIGNON YJ LARRA F LORTHOLARY A PIET L LAITHIER V VUILLIER J DILHUYDY MH LONGY M TOULOUSE C COUETTE JE HARDOUIN A SWITSUS O CHAMOUTON C BIGNON YJ PLAGNE R PETIT MF CURE H CUISENIER J LIZARD S",NIVELON,"TEYSSIER JY",MOUSSEAU,"LEROUX D",VROUSOS,SCHAERER,"VENNIN P DEMAILLE MC DECIGNY N GRANIER AM DEYRAT JP SOBOL H DESSEIGNE F FRAPPAZ D FERVERS B EISINGER F",FABBRO,"LUPORSI E LEHEUP B SOMMELET D MAUGAUDLOUBOUTIN C FRENAY M GESTA P THOMAS G OLSCHWANG S DELETTRE O AURIAS A",ZUMMER,"HAGUENAUER O GRANDJOUAN S DEMANGE L DANELMOORE L LEVEQUE J NOGUES C PETIT JC FRICKER JP LIMACHER JM ROUMAGNAC M LAPEYRE M DREYFUS HR GRANDJOUAN S SCHLUMBERGER M BRUGIERES L JANIN N AVRIL MF
Citation: P. Lalle et al., GENETIC PREDISPOSITION TO BREAST-CANCER A ND OVARIAN-CANCER, Bulletin du cancer, 80(10), 1993, pp. 857-865
Risultati: 1-8 |